Adam R. Kalbermatten, President-Chief Commercial Officer at KORU Medical Systems, Inc. (KRMD), bought 5,000 shares at $3.96 ($20K) on 2026-06-11, disclosed to the SEC on 2026-06-15.
President and Chief Commercial Officer Adam R. Kalbermatten purchased 5,000 shares of KORU Medical Systems for $19,800, marking the largest insider purchase in the company's history. This significant buy by C-suite leadership, occurring after a period of recent insider accumulation, suggests confidence in the company's turnaround and growth trajectory.
The stock is currently trading at $3.91, down 2.25% over the last five days and 8.22% over the past 90 days, but remains up 21.05% over the last year. The current price sits 40.83% below the 52-week high of $6.61.
1) Q2 2026 Earnings on August 12, 2026: The company reported record quarterly revenue and achieved its first profitable quarter since 2019, signaling strong momentum. 2) Q2 2026 Earnings on August 6, 2026: The company reported 18% revenue growth and raised gross margin guidance despite international headwinds and the FESGO withdrawal. 3) Insider Cluster: Four other insiders bought shares in the last 30 days, indicating a coordinated effort to accumulate the stock.
1) High Valuation: The forward P/E ratio is 97.14, which is high for a company that only recently became profitable. 2) Short Interest: The stock has a short interest of 2.12% of the float, which could lead to volatility if the stock price rises.
Nothing distinguishes this filing.